Working toward more effective tuberculosis (TB) vaccines, researchers at Weill Cornell Medicine have developed two strains of ...
Spanish biopharmaceutical company Biofabri and nonprofit scientific research organization IAVI announced today that the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results